New drug duo aims to outsmart Platinum-Resistant ovarian cancer
Disease control
Recruiting now
This phase 2 trial is testing a combination of two drugs—vismodegib and atezolizumab—in people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The goal is to see if the combination is safe and can shrink tumor…
Phase: PHASE2 • Sponsor: Ronald Buckanovich • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC